CRON - Cronos Group Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
11.74
+1.88 (+19.07%)
At close: 4:00PM EDT

12.52 +0.78 (6.64%)
After hours: 7:59PM EDT

Stock chart is not supported by your current browser
Previous Close9.86
Open10.41
Bid12.51 x 2900
Ask12.55 x 1000
Day's Range10.05 - 11.75
52 Week Range5.12 - 15.30
Volume24,860,143
Avg. Volume17,975,790
Market Cap2.097B
Beta (3Y Monthly)3.49
PE Ratio (TTM)1,174.00
EPS (TTM)0.01
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga5 hours ago

    Prohibition Partners Projects $12B Latin American Cannabis Market By 2028

    Prospective investors in cannabis companies like Aphria Inc (OTC: APHQF), Aurora Cannabis Inc (OTC: ACBFF) and Cronos Group Inc (NASDAQ: CRON) should take another metric into account: the companies' Latin American presence. A new report from Prohibition Partners shows that the Latin American cannabis market could reach a value of $12 billion within the next decade. Latin America has a population of over 650 million, but the continent's total health care costs are around $354 billion — significantly smaller than Europe, which has a population of 740 million and health care spending of more than $2.6 trillion.

  • A guide to pot stocks: What you need to know to invest in cannabis companies
    MarketWatch5 hours ago

    A guide to pot stocks: What you need to know to invest in cannabis companies

    Cannabis will be legal in Canada starting this Wednesday, generating strong interest from investors eager to get in on a market that analysts and experts expect to be worth billions of dollars.

  • ACCESSWIRE5 hours ago

    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cronos Group Inc. of Class Action Lawsuit and Upcoming Deadline (CRON)

    NEW YORK, NY / ACCESSWIRE / October 15, 2018 / Pomerantz LLP announces that a class action lawsuit hasbeen filed against Cronos Group Inc. (''Cronos'' or the ''Company'') (CRON) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and index under 18-cv-08406, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired Cronos securities between August 21, 2018 and August 30, 2018, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

  • Marijuana Stocks News: Cronos Stock Surges on Skin Care Treatment News
    InvestorPlace9 hours ago

    Marijuana Stocks News: Cronos Stock Surges on Skin Care Treatment News

    The good marijuana stocks news for Cronos (NASDAQ:CRON) has to do with a recent deal it has with Israel Institute of Technology’s Technion Research and Development Foundation of the Technion. This will have it working on sponsored research into seeing how cannabinoids can affect some skin issues. According to Cronos, this will have it experimenting to see how cannabinoids can affect acne, psoriasis and skin repair.

  • ACCESSWIRE11 hours ago

    Why This Company is Set for a Major Breakout

    HENDERSON, NV / ACCESSWIRE / October 15, 2018 / With the broader market tanking it is likely investors will find safe haven in cannabis and biotech stocks because they are both innovative sectors. An incredibly ...

  • Cronos Group Inc. Partners with Technion Research & Development Foundation for Cannabinoid-Based Skin Care Treatments
    PR Newswire13 hours ago

    Cronos Group Inc. Partners with Technion Research & Development Foundation for Cannabinoid-Based Skin Care Treatments

    TORONTO, Oct. 15, 2018 /PRNewswire/ - Cronos Group Inc. (CRON) (CRON.TO) ("Cronos Group" or the "Company"), announced today that it has entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion - Israel Institute of Technology ("Technion") to explore the use of cannabinoids and their role in regulating skin health and skin disorders. The preclinical studies will be conducted by Technion over a three-year period and will focus on three skin conditions: acne, psoriasis and skin repair. Research will be led by Technion faculty members Dr. David "Dedi" Meiri, Head, Laboratory of Cancer Biology and Cannabinoid Research and Dr. Yaron Fuchs, Head, Laboratory of Cancer Biology and Cannabinoid Research, two of the world's leading researchers in cannabis and skin stem cell research, respectively.

  • Cronos Group Inc. Partners with Technion Research & Development Foundation for Cannabinoid-Based Skin Care Treatments
    CNW Group13 hours ago

    Cronos Group Inc. Partners with Technion Research & Development Foundation for Cannabinoid-Based Skin Care Treatments

    TORONTO , Oct. 15, 2018 /CNW/ - Cronos Group Inc. (CRON) (CRON.TO) ("Cronos Group" or the "Company"), announced today that it has entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion - Israel Institute of Technology ("Technion") to explore the use of cannabinoids and their role in regulating skin health and skin disorders. The preclinical studies will be conducted by Technion over a three-year period and will focus on three skin conditions: acne, psoriasis and skin repair. Research will be led by Technion faculty members Dr. David "Dedi" Meiri , Head, Laboratory of Cancer Biology and Cannabinoid Research and Dr. Yaron Fuchs , Head, Laboratory of Cancer Biology and Cannabinoid Research, two of the world's leading researchers in cannabis and skin stem cell research, respectively.

  • GlobeNewswire3 days ago

    SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cronos Group Inc. of Class Action Lawsuit and Upcoming Deadline – CRON

    NEW YORK, Oct. 12, 2018 -- Pomerantz LLP announces that a class action lawsuit has been filed against Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ:  CRON) and certain.

  • InvestorPlace4 days ago

    Are Pot Stocks Heading Into a “Sell The News” Event?

    Pot stocks have been absolutely on fire over the past few months. It all started with beverage giant Constellation Brands (NYSE:STZ) pouring $4 billion into leading cannabis company Canopy Growth (NYSE:CGC) on August 15, a sign that big money was finally moving into the nascent cannabis sector. Pot stocks have been on fire ever since.

  • GlobeNewswire4 days ago

    SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Cronos Group, Inc. (CRON) and Lead Plaintiff Deadline – November 5, 2018

    NEW YORK, Oct. 11, 2018 -- Attorney Advertising--(PR Newswire)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against.

  • ACCESSWIRE4 days ago

    3 Cannabis Companies Making Headlines in October

    CORAL GABLES, FL / ACCESSWIRE / October 11, 2018 / Thecannabis industry is seeing the birth of strategic investments and new acquisitions this year. Ahead of Canada's national legalization of recreationalmarijuana next week, investors are laser focused on marijuana stocks. "With cannabis, you're talking about this massive step change in terms of the addressable market," Vivien Azer said on CNBC's "Squawk Box" on Wednesday.

  • ACCESSWIRE5 days ago

    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cronos Group Inc. of Class Action Lawsuit and Upcoming Deadline (CRON)

    NEW YORK, NY / ACCESSWIRE / October 10, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Cronos Group Inc. (''Cronos'' or the ''Company'') (NASDAQ: CRON) and certain of ...

  • Business Wire5 days ago

    Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Cronos Group Inc. Investors (CRON)

    Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) securities between August 21, 2018 and August 30, 2018, inclusive (the “Class Period”). Investors that suffered losses on their Cronos investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com. On August 30, 2018, Citron Research published a report alleging that “Cronos management appears to have been deceiving the investing public by purposely not disclosing the size of its distribution agreements with provinces – unlike every other major cannabis player .

  • InvestorPlace5 days ago

    Pyxus Stock Could Backfire Over the Longer Term

    The latest, newest pot stock, Pyxus International (NYSE:PYX), is taking off. Pyxus stock has roughly tripled so far this year, with PYX stock gaining 37% on Monday based on, apparently, a single tweet. Pyxus’ story is intriguing enough that I expect many investors will be willing to look past the risks for some time to come.

  • ACCESSWIRE5 days ago

    These Marijuana Stocks are Getting Ready for Canada's Next Move

    In less than one week, Canada will have legalized recreational marijuana sales and the world will begin to closely monitor progress across the country. During the last year, much has changed including the publicperception of marijuana. Two-thirds of the country is now in support of recreational legalization and polls continue to show backing for medical use at levels far above 80%.

  • If you buy only one marijuana stock, this should be it
    MarketWatch7 days ago

    If you buy only one marijuana stock, this should be it

    Astute investors with experience recognize that while some will make millions by investing in marijuana stocks, most will lose their shirts. This makes sense because of high volatility, stock prices being divorced from fundamentals, pump-and-dump schemes, trading based on sentiment and short-squeezes and occasional frauds. Please see “How to potentially become a marijuana millionaire, albeit carefully.” Investors have been asking me: If I could buy only one marijuana stock, what would it be?

  • GlobeNewswire10 days ago

    LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Cronos Group, Inc. To Contact The Firm

    Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cronos Group Inc. (“Cronos” or the “Company”) (CRON) of the November 5, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

  • GlobeNewswire10 days ago

    SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cronos Group Inc. of Class Action Lawsuit and Upcoming Deadline – CRON

    NEW YORK, Oct. 05, 2018 -- Pomerantz LLP announces that a class action lawsuit has been filed against Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ:  CRON) and certain.

  • MarketWatch10 days ago

    IGC's stock tumbles toward biggest ever decline, again

    Shares of India Globalization Capital Inc. plunged toward its biggest-ever one-day decline, as they extended their pullback following the meteoric run up after the company said it was entering the cannabidiol-infused energy drink space. The stock plummeted 37.1% in afternoon trade, the biggest decline since it went public in April 2006, amid a broad selloff in cannabis stocks. The three biggest declines have occurred over the past three sessions, including a 31.9% selloff on Wednesday and Thursday's 27.6% dive. Before that, the biggest decline was 27.0% on Feb. 19, 2009. The current three-session losing streak follows a near six-fold run up in five days (up 458%). Among other more-active marijuana stocks, New Age Beverages Corp. slipped 0.4%, Tilray Inc. lost 7.2%, Cronos Group Inc. shed 7.7%, Canopy Growth Corp. dropped 3.8% and Aurora Cannabis Inc. gave up 2.3%. Meanwhile, Level Brands Inc.'s stock rallied 14%. The ETFMG Alternative Asset ETF tumbled 3.1% with 27 of 33 components losing ground, while the S&P 500 lost 1.1%.

  • ACCESSWIRE10 days ago

    Pawar Law Group Announces a Securities Class Action Lawsuit Against Cronos Group Inc. - CRON

    NEW YORK, NY / ACCESSWIRE / October 5, 2018 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Cronos Group Inc. (NASDAQ: CRON) from ...

  • GlobeNewswire10 days ago

    SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Cronos Group, Inc. (CRON) and Lead Plaintiff Deadline – November 5, 2018

    NEW YORK, Oct. 05, 2018-- Attorney Advertising---- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Cronos Group, Inc. and certain of its officers, ...

  • 5 Marijuana Stocks to Stay Far Away From
    InvestorPlace11 days ago

    5 Marijuana Stocks to Stay Far Away From

    Just look at Constellation Brands (NYSE:STZ), which invested $3.8 billion in Canopy Growth (NYSE:CGC). Among all the marijuana stocks, Tilray (NASDAQ:TLRY) is one of the higher quality operators. The company has an experienced management team and there should be quite a bit of uptake with the legalization of cannabis for recreational purposes in Canada.

  • GlobeNewswire12 days ago

    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cronos, Skechers and Cocrystal and Encourages Investors to Contact the Firm

    NEW YORK, Oct. 03, 2018 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Cronos Group Inc.,.

  • ACCESSWIRE12 days ago

    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cronos Group Inc. of Class Action Lawsuit and Upcoming Deadline - CRON

    NEW YORK, NY / ACCESSWIRE / October 3, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Cronos Group Inc. ("Cronos" or the "Company") (CRON) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and index under 18-cv-08406, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired Cronos securities between August 21, 2018 and August 30, 2018, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

  • ACCESSWIRE13 days ago

    This Undiscovered Biotech Stock Could Be Poised For A TLRY-Like Breakout

    The next 10 to 20 years will see a host of drugs approved in a new class called Cell Therapies. Orgenesis Inc. (ORGS) is a rapidly growing player in this space with a multi-pronged business model: generating revenue through manufacturing a broad portfolio of cell therapies for some of the biggest players in the space, and with their own in-house development program that could transform the treatment of severe diabetes and other serious medical conditions. Between growing revenue (up 58% in fiscal 2017), attracting an investment from a highly respected institutional investor, and a promising possible treatment for diabetes, Orgenesis is a company to know as Cell Therapies go mainstream.